Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00634166 · ClinicalTrials.gov registry record · Phase 4
Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group
A Phase 4 study, sponsored by Mylan.
- Terminated
- Registry status
- Phase 4
- Development phase
- 220
- Enrollment target
NCT00634166: Clinical Trial Phase 4 study, sponsored by Mylan.
NCT00634166 is a Phase 4 study that was terminated before completion, run by Mylan. The registered enrollment target is 220 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (58% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00634166, a Phase 4 study, was terminated before completion, sponsored by Mylan.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 220 participants
- Enrollment target
Study Summary
The primary objective is to compare the effectiveness of treatment with Sulfamylon® solution as the initial topical moist dressing over meshed autografts following the initial graft procedure on preventing graft loss in a prospective cohort of subjects versus a historical control group in a non-inferiority trial.
Interventions
- DRUG Sulfamylon® For 5 % Topical Solution
- DRUG Topical Antimicrobial/Antifungal Medications
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2007-09 |
| Est. Completion | 2014-04 |
| Phase | Phase 4 |
Why NCT00634166 stopped before completion
NCT00634166 is an interventional study that assigns participants to a tested intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (58% lower).
The record links to 0 conditions, and to 2 interventions - of which Sulfamylon® For 5 % Topical Solution is the first listed.
NCT00634166 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00634166 about?
NCT00634166 is a clinical study titled "Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group". The primary objective is to compare the effectiveness of treatment with Sulfamylon® solution as the initial topical moist dressing over meshed autografts following the initial graft procedure on preventing graft loss in a prospective cohort of subjects versus a historical control group in a non-infe...
What is the current status of trial NCT00634166?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 220 participants. The study started on 2007-09. Estimated completion is 2014-04.
What interventions are being tested in trial NCT00634166?
The interventions under investigation include: Sulfamylon® For 5 % Topical Solution (DRUG), Topical Antimicrobial/Antifungal Medications (DRUG).
Who is sponsoring clinical trial NCT00634166?
This trial is sponsored by Mylan, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00634166's enrollment target sits among peer trials
220 385th of 2000 higher than 1,612 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00920972 · 220 participants · Phase 1
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
- NCT01851642 · 220 participants
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
- NCT02582021 · 220 participants
WISE CVD - Continuation (WISE HFpEF)
- NCT04067830 · 220 participants · Phase 2
Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia